Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00444353 · ClinicalTrials.gov registry record · Phase 3
DL6049 Versus Cosmoplast in the Treatment of Nasolabial Fold Wrinkles, Long Term Follow-up
A Phase 3 study, sponsored by Bausch Health Americas.
- Completed
- Registry status
- Phase 3
- Development phase
- 240
- Enrollment target
NCT00444353 is a Phase 3 study that has completed, run by Bausch Health Americas. The registered enrollment target is 240 participants.
The verdict
NCT00444353, a Phase 3 study, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 240 participants
- Enrollment target
Study Summary
This study is being undertaken to: * evaluate the degree of correction attainable with DL6049 (injectable poly-L-lactic acid)compared to a commercially available CosmoPlast™ Collagen Implant in the treatment of dermal nasolabial fold wrinkles at 13 months following the last application of study treatment. * Document the types and incidence of adverse events reported with DL6049 (injectable poly-L-lactic acid)compared with CosmoPlast™ Collagen Implant. Long term adverse events will be assessed for an additional 12 months following discharge from the main study in subjects treated with DL6049.
Interventions
- DEVICE DL6049 (injectable poly-L-lactic acid)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2004-08 |
| Est. Completion | 2007-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00444353
The ClinicalTrials.gov registry entry for NCT00444353 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch Health Americas, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DL6049 (injectable poly-L-lactic acid) is the first listed.
NCT00444353 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00444353 about?
NCT00444353 is a clinical study titled "DL6049 Versus Cosmoplast in the Treatment of Nasolabial Fold Wrinkles, Long Term Follow-up". This study is being undertaken to: * evaluate the degree of correction attainable with DL6049 (injectable poly-L-lactic acid)compared to a commercially available CosmoPlast™ Collagen Implant in the treatment of dermal nasolabial fold wrinkles at 13 months following the last application of study tre...
What is the current status of trial NCT00444353?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 240 participants. The study started on 2004-08. Estimated completion is 2007-01.
What interventions are being tested in trial NCT00444353?
The interventions under investigation include: DL6049 (injectable poly-L-lactic acid) (DEVICE).
Who is sponsoring clinical trial NCT00444353?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.